期刊
INTENSIVE CARE MEDICINE
卷 34, 期 8, 页码 1434-1440出版社
SPRINGER
DOI: 10.1007/s00134-008-1112-x
关键词
ventilator-associated pneumonia; procalcitonin; diagnosis; clinical pulmonary infection score
Objective: To assess the predictive capacity for the diagnosis of ventilator-associated pneumonia (VAP) of serum procalcitonin levels before and on the day it is suspected. Design and setting: Single-center observational study in the intensive care unit of a teaching hospital. Patients and participants: Consecutive patients whose serum procalcitonin levels were available on the day that VAP was clinically suspected (day 1) and at some time within the preceding 5 days (before). Measurements and results: Serum procalcitonin levels were determined on day 1 and before. Among the 73 suspected episodes VAP was confirmed by quantitative bronchoalveolar lavage cultures in 32 and refuted in 41. Respective median before procalcitonin levels were 1.89 ng/ml (interquartile range 0.18 - 6.01) and 2.14 (0.76 - 5.75) in patients with and without VAP, but their respective median day-1 procalcitonin levels did not differ: 1.07 ng/ml (0.39 - 6.57) vs. 1.40 (0.67 - 3.39). On day 1 a 0.5 ng/ml procalcitonin threshold had 72% sensitivity but only 24% specificity for diagnosing VAP. Between before and day 1, procalcitonin increased in 41% and 15% of patients with and without VAP, respectively. Thus a procalcitonin rise on day 1, compared to its before level, had 41% sensitivity and 85% specificity for diagnosing VAP, with respective positive and negative predictive values of 68% and 65%. Conclusions: Crude values and procalcitonin rise had poor diagnostic value for VAP in this particular setting and thus should not be used to initiate antibiotics when VAP is clinically suspected.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据